Edwards Lifesciences Past Earnings Performance
Past criteria checks 2/6
Edwards Lifesciences has been growing earnings at an average annual rate of 14%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 8.8% per year. Edwards Lifesciences's return on equity is 19.6%, and it has net margins of 23%.
Key information
14.0%
Earnings growth rate
14.6%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 8.8% |
| Return on equity | 19.6% |
| Net Margin | 23.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Edwards Lifesciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 6,143 | 1,414 | 1,877 | 1,096 |
| 31 Dec 23 | 6,005 | 1,402 | 1,823 | 1,072 |
| 30 Sep 23 | 5,819 | 1,431 | 1,755 | 1,034 |
| 30 Jun 23 | 5,657 | 1,390 | 1,692 | 997 |
| 31 Mar 23 | 5,501 | 1,489 | 1,633 | 978 |
| 31 Dec 22 | 5,382 | 1,522 | 1,567 | 945 |
| 30 Sep 22 | 5,364 | 1,459 | 1,581 | 946 |
| 30 Jun 22 | 5,355 | 1,455 | 1,568 | 950 |
| 31 Mar 22 | 5,357 | 1,539 | 1,534 | 925 |
| 31 Dec 21 | 5,233 | 1,503 | 1,494 | 903 |
| 30 Sep 21 | 5,095 | 1,477 | 1,409 | 866 |
| 30 Jun 21 | 4,925 | 1,462 | 1,351 | 824 |
| 31 Mar 21 | 4,474 | 851 | 1,252 | 780 |
| 31 Dec 20 | 4,386 | 823 | 1,229 | 761 |
| 30 Sep 20 | 4,369 | 794 | 1,235 | 759 |
| 30 Jun 20 | 4,322 | 744 | 1,234 | 759 |
| 31 Mar 20 | 4,484 | 1,108 | 1,268 | 769 |
| 31 Dec 19 | 4,348 | 1,047 | 1,242 | 753 |
| 30 Sep 19 | 4,152 | 774 | 1,182 | 722 |
| 30 Jun 19 | 3,964 | 725 | 1,146 | 688 |
| 31 Mar 19 | 3,821 | 765 | 1,113 | 650 |
| 31 Dec 18 | 3,723 | 722 | 1,088 | 622 |
| 30 Sep 18 | 3,634 | 712 | 1,080 | 606 |
| 30 Jun 18 | 3,549 | 657 | 1,055 | 587 |
| 31 Mar 18 | 3,447 | 560 | 1,023 | 567 |
| 31 Dec 17 | 3,435 | 584 | 984 | 553 |
| 30 Sep 17 | 3,315 | 745 | 948 | 521 |
| 30 Jun 17 | 3,232 | 716 | 933 | 491 |
| 31 Mar 17 | 3,150 | 657 | 918 | 469 |
| 31 Dec 16 | 2,964 | 570 | 905 | 442 |
| 30 Sep 16 | 2,867 | 552 | 892 | 426 |
| 30 Jun 16 | 2,743 | 528 | 875 | 414 |
| 31 Mar 16 | 2,601 | 515 | 860 | 399 |
| 31 Dec 15 | 2,494 | 495 | 851 | 383 |
| 30 Sep 15 | 2,441 | 463 | 852 | 369 |
| 30 Jun 15 | 2,433 | 440 | 862 | 356 |
| 31 Mar 15 | 2,391 | 874 | 863 | 347 |
| 31 Dec 14 | 2,323 | 811 | 858 | 347 |
| 30 Sep 14 | 2,241 | 777 | 822 | 341 |
| 30 Jun 14 | 2,129 | 759 | 777 | 338 |
| 31 Mar 14 | 2,071 | 306 | 748 | 329 |
| 31 Dec 13 | 2,046 | 389 | 733 | 323 |
| 30 Sep 13 | 2,020 | 405 | 724 | 319 |
| 30 Jun 13 | 1,972 | 398 | 714 | 309 |
Quality Earnings: EWL has high quality earnings.
Growing Profit Margin: EWL's current net profit margins (23%) are lower than last year (27.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EWL's earnings have grown by 14% per year over the past 5 years.
Accelerating Growth: EWL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: EWL had negative earnings growth (-5%) over the past year, making it difficult to compare to the Medical Equipment industry average (-9.8%).
Return on Equity
High ROE: EWL's Return on Equity (19.6%) is considered low.